In addition, some studies have reported that triptolide can inhibit the expression of interferon-γ (IFN-γ)-induced programmed death-1 ligand-1 (PD-L1) on the surface of tumor cells and reverse the inhibitory effect of tumor cells on CD4+ T cells. Here, CD4 is linked to neoplasm.